R. Juthani , K. Pugh , C.M. Eochagain , C. Soudant , P. Torka , N.R. Neuendorff
{"title":"2017年至2023年FDA和EMA批准的弥漫性大b细胞淋巴瘤注册试验中老年亚组的报告:一项系统综述","authors":"R. Juthani , K. Pugh , C.M. Eochagain , C. Soudant , P. Torka , N.R. Neuendorff","doi":"10.1016/j.jgo.2026.102877","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102877"},"PeriodicalIF":2.9000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reporting of older subgroups in registration trials of FDA and EMA approvals between 2017 and 2023 for diffuse large B-cell lymphoma: A systematic review\",\"authors\":\"R. Juthani , K. Pugh , C.M. Eochagain , C. Soudant , P. Torka , N.R. Neuendorff\",\"doi\":\"10.1016/j.jgo.2026.102877\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":15943,\"journal\":{\"name\":\"Journal of geriatric oncology\",\"volume\":\"17 2\",\"pages\":\"Article 102877\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2026-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of geriatric oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1879406826000317\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/3/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of geriatric oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1879406826000317","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/13 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
Reporting of older subgroups in registration trials of FDA and EMA approvals between 2017 and 2023 for diffuse large B-cell lymphoma: A systematic review
期刊介绍:
The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.
The journal welcomes the submission of manuscripts in the following categories:
• Original research articles
• Review articles
• Clinical trials
• Education and training articles
• Short communications
• Perspectives
• Meeting reports
• Letters to the Editor.